| UPSA Switzerland AG - Dafalgan Direct, Schmelztabletten | | 55138 | | 02 | | Dafalgan Direct | | Schmelztabletten | | N02BE01 | | Paracetamol | | 18.10.2013 | | |
| | Composition | | paracetamolum 500 mg, ethylcellulosum, acidum citricum, natrii hydrogenocarbonas, sorbitolum 30.5 mg, natrii carbonas, saccharum 105.83 - 109.17 mg, maltodextrinum et glucosum 2.23 - 5.57 mg et crospovidonum, E 211 25 mg, aspartamum 4.8 mg et acesulfamum kalicum, aromatica, pro compresso corresp. natrium 39 mg. | | Packungsbestandteile | | Comprimés orodispersibles | | | | Principe actif | Concentr. |
|---|
| Paracetamole | 500 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acesulfamum Kalicum | | | | Acide Citrique | | | | Aromatica | | | | Aspartame | 4.8 mg | | | Crospovidonum | | | | E 211 | 25 mg | conserv. | | Ethylcellulosum | | | | Glucose | 2.23-5.57 mg | | | Maltodextrine | | | | Sodium Carbonate | | | | Sodium Hydrogenocarbonate | | | | Pro Compresso | | | | Saccharum | 105.83-109.17 mg | | | Sorbitol | 30.5 mg | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 16 | | | D | | Non |
|
|
